ArkeaBio™ Email Format

Biotechnology ResearchMassachusetts, United States11-50 Employees

ArkeaBio is a biotechnology research company based in Charlestown, Massachusetts, focused on developing a vaccine to reduce methane emissions from cattle on a global scale. It has demonstrated a proof-of-concept for the vaccine and aims to offer a scalable, cost-effective approach to mitigating greenhouse gases in agriculture, with anticipated benefits for farmers, brands, consumers, and the climate.

The firm operates in the agricultural bioscience segment and positions itself as a global player addressing emissions in livestock production. It remains headquartered in Charlestown, Massachusetts, and continues to advance its vaccine program within the biotechnology research industry. In August 2025, ArkeaBio announced the appointment of Dr. Zach Serber as Chief Technology Officer to lead the company’s technology development efforts.

Sign up for free to view info

Company overview Employee directory